MedPath

Epilepsy Smart Schools in India

Phase 4
Registration Number
CTRI/2024/02/062352
Lead Sponsor
Director General , Indian Council of Medical Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

School children of India in government schools

Exclusion Criteria

School children of India not studying in government schools

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Health Outcomes : <br/ ><br>i. Occurrence and incidence of epileptic seizures during school hours. <br/ ><br>ii. Seizure Control and Quality of Life <br/ ><br>iii. Number of Injuries and accidents related to seizures. <br/ ><br>iv. Improved management of comorbidities <br/ ><br>2. Education-related <br/ ><br>i. Scholastic Performance of children with epilepsy in schools. <br/ ><br>ii. School dropout rate. <br/ ><br>3. Acceptability <br/ ><br>i. Improvement in Knowledge, Attitude and Practices of stakeholders. <br/ ><br>ii. Cost-effectiveness of the intervention model. <br/ ><br>Timepoint: 12 months after the intervention
Secondary Outcome Measures
NameTimeMethod
1.To document the occurrence and incidence of epileptic seizures during school hours. <br/ ><br>2.To assess the feasibility, acceptability and adoptability of the school-based tele-intervention among school personnel, primary health care providers and parents of children with epilepsy. <br/ ><br>3.To assess baseline Knowledge, Attitude and Practices (KAP) regarding epilepsy among school personnel, primary health care providers and parents of children with epilepsy. <br/ ><br>4.To determine the impact of the intervention on KAP and a range of outcomes (Seizure control, adherence, quality of life, injuries and accidents, educational outcomes) for children with epilepsy. <br/ ><br>5.To determine the cost implications of the initiative. <br/ ><br>Timepoint: 24 and 36 months
© Copyright 2025. All Rights Reserved by MedPath